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A B S T R A C T
Phytoecdysteroids exert their non-hormonal anabolic and adaptogenic effects in mammals, including humans,
through a partially revealed mechanism of action involving the activation of protein kinase B (Akt). We have
recently found that poststerone, a side-chain cleaved in vivo metabolite of 20-hydroxyecdysone, exerts potent
anabolic activity in rats.
Here we report the semi-synthetic preparation of a series of side-chain cleaved ecdysteroids and their activity
on the Akt phosphorylation in murine skeletal muscle cells. Twelve C-21 ecdysteroids including 8 new com-
pounds were obtained through the oxidative side-chain cleavage of various phytoecdysteroids, or through the
base-catalyzed autoxidation of poststerone. The complete 1H and 13C NMR spectroscopic assignments of the new
compounds are presented. Among the tested compounds, 9 could activate Akt stronger than poststerone re-
vealing that side-chain cleaved derivatives of phytoecdysteroids other than 20-hydroxyecdysone are valuable
bioactive metabolites. Thus, our results suggest that the expectable in vivo formation of such compounds should
contribute to the bioactivity of herbal preparations containing ecdysteroid mixtures.
1. Introduction
The global phenomenon of population ageing directs an increasing
attention towards natural approaches to maintain health and strength
in general, and supplementation with herbal adaptogens and/or natural
anabolic agents provides an attractive way to achieve this.
Phytoecdysteroids are among the most popular options in this regard.
Ecdysteroids are a large and diverse family of polyhydroxylated
sterols; there are more than 500 representatives of these compounds
currently known to occur in Nature [1]. Concerning their chemistry,
most of them possess a C27 carbon skeleton derived biosynthetically
from cholesterol. However, the number of carbon atoms can vary. Ec-
dysteroids occur as C27, C28, or C29 compounds if the whole sterol-type
side chain is present, or they can be C19, C21, or C24 compounds if a
partial or complete metabolic side-chain cleavage takes place between
C17-C20, C20-C22 or C24-C25, respectively. Most of the naturally occur-
ring phytoecdysteroids possess a 7-en-6-one chromophore group in the
ring B. The A/B ring junction is normally cis, whereas the B/C and C/D
ring junctions are almost always trans [2].
Ecdysteroids were initially discovered as the molting hormones of
insects [3], but soon after they were also isolated from Plant Kingdom,
where their concentration can reach as much as 1,000-fold higher than
that typically found in arthropods [4]. Phytoecdysteroids can reach as
much as 2–3% of the dry weight in some species (e.g. seeds of Rha-
ponticum carthamoides and stalks of Diploclisia glaucescens, in-
florescences of Serrulata inermis and roots of Cyanotis arachnoidea) [5].
It is important to note that while plants’ ecdysteroid composition is
typically dominated by a few major ecdysteroids (usually 20-hydro-
xyecdysone; 20E), a complex cocktail of minor compounds is generally
present whose bioactivity needs to be taken into account when ecdys-
teroid-containing herbal preparations are used.
It is generally accepted that phytoecdysteroids do not interact with
the vertebrate steroid hormone system. Still, they exert numerous
beneficial effects on mammals (e.g. anabolic, adaptogenic, antidiabetic,
hypolipidemic, hepatoprotective, etc.), while their acute toxicity is
negligible [4–10]. Phytoecdysteroids have long been known for their
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complex bioactivity that could be referred to as a broad-spectrum,
general strengthening effect. Several in vitro and in vivo studies con-
firmed the anabolic activity of ecdysteroids that is characterized by an
increase in growth and skeletal muscle mass [11–12], as well as in the
fiber size through muscle-specific effects [13] in different animals. The
exact mechanism of action behind this anabolic activity is only partially
understood, and needs further clarification. Recently, Gorelick-Feldman
et al. found that 20E (1) caused a hasty elevation in intracellular cal-
cium levels, leading to a maintained activation of protein kinase B (Akt)
and to an increased protein synthesis in a mouse skeletal muscle cell
line (C2C12) [14]. Protein kinase B and its downstream effectors, inter
alia, represent a major signaling pathway that controls protein turnover
in skeletal muscles, and this function appears to be maintained in
ageing muscles as well [15–16]. This role makes it an appropriate target
to test ecdysteroids for their anabolic “strengthening” potential. Ac-
tivity on this pathway can also provide indirect information on the
capacity of ecdysteroids to promote muscle gain and/or prevent muscle
loss.
The possible role of in vivo metabolites of ecdysteroids in the ob-
served bioactivities has long been part of related scientific discussion.
Recent studies of Kumpun et al. identified several metabolites in the
urine and feces of mice treated by an intraperitoneal injection of 20E
(1) [17]. Side chain cleavage between C-20 and C-22, and dehydrox-
ylation at C-14 were identified as major metabolic steps, thus yielding
poststerone (7), 14-deoxy-20-hydroxyecdysone and 14-deoxypost-
sterone, which then undergo a reductive metabolism in several further
steps [17]. We have recently found that poststerone (7) acts as a potent
anabolic agent on rat skeletal muscles in vivo, implying that it plays an
important role in the in vivo anabolic activity of its parental compound
20E (1) (unpublished results; manuscript by Csábi et al. is currently
under evaluation at Sci. Rep., first submission: 26.04.2018).
Accordingly, it seems reasonable to assume that side-chain cleaved
metabolites of phytoecdysteroids other than 20E (1) might also arise in
vivo, and that these metabolites are also valuable bioactive compounds.
The base-catalyzed autoxidation of 20E (1), first described by
Suksamrarn et al. in 1994 [18], was recently found by our research
group to yield several oxidized derivatives exerting stronger activity on
the Akt phosphorylation in murine skeletal muscle cells as compared to
their parental compound 20E (1) [19]. This, together with the in vivo
relevance of poststerone (7), led us to rise the following objectives for
the present study: (i) to prepare a series of new C-21 ecdysteroid de-
rivatives by using oxidative side-chain cleavage on various phy-
toecdysteroids or through the autoxidation of poststerone (7), and (ii)
to evaluate the compounds’ activity on the protein kinase B activation
in murine skeletal muscle cells.
2. Results and discussion
2.1. Chemistry
2.1.1. Preparation of ecdysteroids 7–12 through oxidative side-chain
cleavage
Oxidative side-chain cleavage of different phytoecdysteroids (1–6)
was performed by using either the hypervalent iodine reagent [bis
(trifluoroacetoxy)iodo]benzene (PIFA) or (diacetoxyiodo)benzene
(PIDA).
Poststerone (7) was previously published to form when oxidizing
20E (1) with NaIO4 (yield not reported) [20] or with Jones reagent
(62% yield) [21]. Our recently published procedure, using PIFA for the
same oxidation, could provide compound 7 in a yield of 57.8% [22]. In
the present study, we report an update to this reaction: when using
PIDA in a large-scale reaction followed by purification with flash
Fig. 1. Preparation of ecdysteroid derivatives through oxidative side-chain cleavage.
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chromatography, poststerone (7) could be obtained in a decent isolated
yield of 81.41%.
In order to obtain side-chain cleaved analogs (i.e. likely major in
vivo metabolites) of other phytoecdysteroids, the reaction was also
carried out on natural ecdysteroids with different substituents on the
steroid skeleton, namely 2-deoxy-20-hydroxyecdysone (2), ajugas-
terone C (3), polypodine B (4), and dacryhainansterone (5) with the use
of PIFA, and calonysterone (6) with the use of PIDA as reagent. Since
these compounds were available in lower amounts than 20E (1),
smaller scale reactions were performed. Preparative reverse-phase
HPLC (RP-HPLC) was applied to obtain compounds 8 and 9, rotation
planar chromatography (RPC) was used to obtain compounds 10 and
11, and centrifugal partition chromatography (CPC) was utilized to
obtain compound 12. Structures of the starting materials and their re-
spective analogs are presented in Fig. 1.
For comparison purposes, reactions first performed with the use of
PIFA as reagent were also carried out also by using PIDA instead. Less
complex mixtures were obtained this way, and the expected products
were obtained with the following yields: 8 (68.34%), 9 (63.57%), 10
(71.23%) and 11 (82.71%). Based on these comparative experiments,
we could conclude that the use of PIDA as reagent instead of PIFA
provides higher yields of the desired C-21 ecdysteroids. We hypothesize
that the reason for this is decomposition due to by-product TFA that
strongly acidifies the reaction medium when using PIFA, while acetic
acid released by PIDA provides milder conditions leading to less com-
plex mixtures and higher final yields of the target compounds.
2.1.2. Preparation of autoxidized derivatives 13–18 of poststerone (7)
Considering our previous observations on the significant bioactivity
changes connected to certain autoxidized derivatives 20E (1) [19], our
second aim was to prepare similar derivatives from poststerone (7),
which would likely represent in vivo relevant metabolites of the corre-
sponding analogs obtained from 20E (1). The base-catalyzed auto-
xidation of poststerone (7) was carried by dissolving the starting ma-
terial in methanol - water (9:1, v/v) and subsequently NaOH was added
to the mixture as a catalyst. The reaction mixture was stirred for 4 h,
stopped by neutralizing the pH with 9.6% acetic acid, extracted through
silica and dried. The dry residue was fractionated by centrifugal par-
tition chromatography (CPC) in ascending mode, with a biphasic sol-
vent system composed of ethyl acetate - water - methanol (20:20:1, v/
v/v). Combined fractions were further purified by RP-HPLC to obtain
compounds 13–18. Compound 12 was also identified from this reac-
tion, but its preparation from calonysterone (6) was more preferable
due to the much higher yield. Structures of the synthesized derivatives
(13–18) are presented in Fig. 2.
In order to allow biological testing of the isolated products, larger
amounts were required. To achieve this, a set of small-scale reactions
were performed, and the degradation of poststerone (7) and the for-
mation of its oxidized derivatives (12–18) were monitored by normal
phase (NP-TLC). As a result, we found that a longer reaction time of ca.
7–9 h is preferable to increase the yield of the targeted compounds.
Thus, the same reaction was conducted for 7 h using 500mg of post-
sterone (7), followed by the same purification steps as before. Yields of
compounds 13, 15, 16 and 18 increased by 2.46, 1.59, 4.81, 1.10 times
respectively. On the other hand, compound 17 was not detected any-
more after 4 h.
2.2. Structure elucidation
Structure elucidation of the products was performed by means of
comprehensive one- and two-dimensional NMR methods using widely
accepted strategies [23–24], and we established the compounds' com-
plete 1H and 13C signal assignment. Most 1H assignments were ac-
complished using general knowledge of chemical shift dispersion with
the aid of the 1H–1H coupling pattern (1H NMR spectra). 1H NMR
chemical shifts of overlapped signals were identified by 2D HSQC and
HMBC experiments, and by utilising 1D selective ROESY (Rotating
frame Overhauser Enchancement Spectroscopy) responses or 1D se-
lective TOCSY experiments.
Compounds 7, 9 and 11 (poststerone, 11α-hydroxypoststerone and
9,11-didehydropoststerone, respectively) [22,25–26], were previously
isolated and fully characterized by our research group; their 1H and 13C
NMR chemical shifts correlated well with the values reported earlier.
HPLC chromatograms and UV spectra of compounds 7, 9 and 11 are
available as Supplementary Information (Figs. S46, S48, and S50, re-
spectively).
The 1H and 13C NMR chemical shifts of the eight new compounds (8,
10, 12, 14–18), together with the data of poststerone as reference (7),
are compiled in Table 1 and 2.
The side-chain cleavage of phytoecdysteroids (1–6) took place be-
tween the two hydroxylated carbon atoms C-20 and C-22, and led to the
formation of a CH3-C]O group attached to C-17 as it is straightforward
Fig. 2. Structure of the isolated compounds 13–18.
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from the δH3-21 signals around 2.16 ppm, and the δC-21 and δC-20
peaks at ∼31 and ∼212 ppm, respectively (see Table 1 and 2). It
should be mentioned that the 13C signals of the steroid skeleton of the
starting compounds showed only moderate changes upon side chain
cleavage.
Compound 8 presented similar UV spectrum as its parental com-
pound, 2-Deoxy-20-hydroxyecdysone (2), indicating no change in the
chromophore. By means of MS, molecular weight of compound 8 was
determined as m/z=347 [M+H]+, suggesting that the side-chain
was successfully cleaved between C20-22, resulting in the molecular
formula C21H30O4. HPLC chromatogram and UV spectrum of compound
8 are available as Supplementary Information: Fig. S47, together with
the NMR spectra: Fig. S1–Fig. S6. In the 1H spectrum taken at 27 °C,
some signals of the A/B rings appeared rather broadened, but when
raising the temperature up to 50 °C they became sharp, and the band-
width at half maximum of the H-3 signal changed from 21Hz to 11 Hz,
whereas the broad coalescence-like H-9 signal turned into a ddd mul-
tiplet with 4J(H-9,H-7)= 2.5 Hz, 3J(H-9,Hα-11)= 6.8 Hz and 3J(H-
9,Hβ-11)= 11.9 Hz couplings. Similar line-broadening was observed
with the 13C signals. Even at 50 °C, in the edited DEPTQ spectrum (Fig.
S3), from the five CH atoms (upside signals), only four: C-7, C-3, C-17
and C-5 appeared, whereas C-9, around 35 ppm, remained under the
noise level due to the strong broadening. The exact δC-9=35.5 ppm
value was established from the H-9/C-9 cross-peak of HSQC spectrum
(Fig. S4). Utilizing the edited HSQC spectrum (Fig. S5), the assignment
of the two broad methylene signals (δC-11=22.1, δC-1=30.0 ppm)
can also be verified. The HMBC spectrum (Fig. S6) provided H/C cor-
relations (2,3J(H,C) over two and three bonds, supporting the structure
and the assignment even for the quaternary carbon atoms. Considering
the inserted H3-19/C and H3-18/C section of HMBC, the cross-peaks of
H3-19 methyl hydrogens unambiguously assigned the quaternary C-10,
tertiary C-5 and C-9, and secondary C-1 signals, and the H3-18 hydro-
gens identified the quaternary C-13 and C-14, tertiary C-17 and sec-
ondary C-12 signals. Differentiation between the α/β positions of hy-
drogen atoms in the poststerone core, and also confirming the cis-type
junction of the A/B rings were achieved through the one-dimensional
selective ROESY experiments with irradiation of the H3-18 and H3-19
hydrogen atoms (Fig. S3). We have previously proven that, in case of
studying ecdysteroids at 500MHz frequency, this approach provide a
sensitivity that strongly exceeds that of the analogous selective NOE
(Nuclear Overhauser-Enhancement) experiment [27].
While in case of compound 8 we observed a temperature dependent
signal broadening/sharpening, indicating a slow interconversion of
different conformers, such a phenomenon did not occur in the case of
poststerone (7). Such a different behavior of these compounds is likely
due to the fact that in compound 7 the A ring of the 5β cis-linked A/B
steroid frame predominantly appears in a chair conformation with
equatorial HO-2 and axial HO-3 groups. Despite of the axial position of
HO-3 group, the equatorial HO-2 substituent stabilizes this conformer.
In compound 8, however, there is only one unfavorable axial HO-group,
allowing the appearance of such twisted-boat conformer(s) where the
substituent is no more axial (see Fig. S5). The slow interconversion of
these conformers could explain the reported coalescence in the 1H and
13C spectra.
Table 1
1H chemical shift of compounds 7, 8, 10, 12, 14–18 in methanol‑d4 and 18 also
in dimethyl sulfoxide-d6 (18a).
Atom no. 7 8 10 12 14 15 16 17 18 18a
1 α 1.80 1.62 1.74* 1.38 2.17 1.46 2.03 1.93 1.96 1.84
β 1.44 1.47 1.74* 2.44 1.71 2.32 1.70 1.62 2.21 2.08
2 α 3.86 1.81 3.96 4.01 4.01 4.01 3.77 3.48 – –
β – 1.66 – – – – – – – –
3 3.97 3.98 4.00 3.53 3.55 3.51 3.88 3.94 3.79 3.61
4 α 1.74 1.81 2.08 3.13 1.91 3.11 1.38 1.79 2.16 1.98
β 1.74 1.57 1.78 2.54 1.75 2.53 1.80 1.70 1.81 1.61
5 2.39 2.44 – – 3.17 – 2.62 2.49 2.43 2.29
7 α 5.82 5.81 5.87 – 5.84 – – 3.33 5.76 5.64
β – – – – – – – 2.69 – –
9 3.19 3.25 3.23 – – – – – – –
11 α 1.89 1.81 1.89 2.73 1.80 2.63* 6.04 2.41 2.06 1.97
β 1.67 1.63 1.73 2.65 2.07 2.63* – 2.41 1.81 1.62
12 α 2.33 2.32 2.33 1.74 2.36 2.26 2.52 1.80 2.35 2.21
β 1.82 1.79 1.83 2.33 1.78 1.93 2.73 2.30 1.82 1.71
15 α 1.70 1.69 1.69 6.81 1.75 2.63 6.79 5.45 1.62 1.50
β 2.00 2.02 2.00 – 1.97 2.00 – – 1.94 1.84
16 α 1.88 1.90 1.88 2.38 1.87 1.90 2.46 2.31 1.89 1.72
β 2.23 2.24 2.25 2.98 2.25 2.25 3.01 2.90 2.24 2.09
17 3.33 3.34 3.33 3.00 3.35 3.16 3.11 3.04 3.33 3.20
18 0.62 0.63 0.63 0.80 0.65 0.66 0.82 0.78 0.64 0.50
19 0.96 0.96 0.91 1.50 1.10 1.50 1.13 1.01 1.05 0.93
21 2.16 2.14 2.15 2.22 2.16 2.17 2.23 2.21 2.16 2.10
* Signals that are accidentally isochrones.
a OH signals of compound 18: 2-OH 6.63 s; 3-OH 5.00 d 3.9 Hz; 14-OH
4.49 s.
Table 2
13C chemical shifts of compounds 7, 8, 10, 12, 14–18 in methanol‑d4 and 18 also in dimethyl sulfoxide-d6 (18a).
Atom no. 7 8 10 12 14 15 16 0 18 18a
1 37.4 30.0 34.3 39.5 36.1 42.1 37.7 38.1 39.2 37.8
2 68.7 29.1 68.5 72.8 70.8 70.3 68.7 70.0 109.0 107.8
3 68.5 65.6 70.3 73.7 72.5 73.5 68.0 68.6 72.3 70.1
4 32.9 33.3 36.2 27.6 24.7 27.5 35.9 33.2 35.1 34.0
5 51.9 52.4 80.4 133.6 49.0 133.7 49.7 54.1 53.1 51.2
6 206.3 206.2 202.3 144.2 202.7 144.6 199.1 215.0 204.8 202.4
7 122.6 122.4 120.1 181.2 125.3 180.9 144.8 39.8 122.6 120.8
8 166.6 167.1 166.1 124.7 158.8 133.0 118.7 123.8 153.8 152.4
9 35.2 35.3 39.1 165.5 76.2 168.2 137.1 137.4 83.2 80.7
10 39.3 37.7 45.5 42.2 43.7 42.6 41.9 44.3 48.9 47.3
11 21.7 22.1 22.7 25.6 29.1 25.4 125.9 23.8 31.5 29.7
12 31.1 31.4 31.2 36.7 28.4 28.4 40.9 37.0 28.7 26.9
13 48.9 49.4 49.0 48.1 49.0 49.2 48.0 47.5 49.65 47.8
14 85.1 85.3 84.9 140.3 86.4 82.1 142.2 147.3 87.3 84.9
15 32.2 32.1 32.1 127.4 31.7 33.7 134.1 120.1 31.2 29.9
16 22.3 22.4 22.2 33.6 22.1 23.8 33.9 32.7 22.2 20.6
17 60.2 60.3 60.1 63.9 60.1 58.5 64.5 66.0 59.7 57.9
18 17.6 17.6 17.6 18.3 17.6 18.1 20.0 17.8 18.4 17.3
19 24.5 24.5 17.1 27.6 19.8 28.6 30.9 29.6 21.0 20.3
20 212.6 212.5 212.5 211.9 212.4 213.4 211.4 211.6 212.5 209.3
21 31.6 31.6 31.6 31.6 31.6 31.7 31.4 31.5 31.5 31.1
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The UV spectrum of compound 10 was practically identical with
that of its parental compound, polypodine B (4), indicating no change
in the chromophore. By means of MS, its molecular weight was estab-
lished as m/z=401 [M+Na]+, suggesting that the side-chain was
cleaved between C20-22, resulting in a molecular formula of C21H30O6.
The HPLC chromatogram along with the UV spectrum of compound 10
is available as Supplementary Information: Fig. S49, together with NMR
spectra: Fig. S7–Fig. S14. In the hydrogen and carbon spectra, taken at
27 °C, no line-broadening were observed. The δH-9= 3.23 ppm signal
appeared as ddd multiplet with 4J(H-9,H-7)= 2.5 Hz, 3J(H-9,Hα-
11)= 6.8 Hz and 3J(H-9,Hβ-11)= 11.5 Hz couplings. In accordance
with the expected structure of 10, the DEPTQ spectrum (see Fig. S8)
revealed the signals of three CH3, six CH2, four sp3 CH, one =CH, and
seven quaternary carbon atoms. Among the quaternary carbons, four
sp3 and three sp2 hybrids could be identified. An inspection of the
routine HSQC spectrum (Fig. S10 and S11) showed that the diaster-
eotopic Hα-1 and Hβ-1 atoms are accidentally isochrones, whereas, due
to the moderate resolution in the 13C range, an adequate assignment of
the C-11 and C-16 signals (22.7/22.2 ppm) is not possible. By utilizing
the band-selective version of the two-dimensional HSQC measurement
in the corresponding area (37–21 ppm) (Fig. S12), a perfect separation
of the overlapping cross-peaks (δHα-11/δC-11: 1.89/22.7 and δHα-16/
δC-16: 1.88/22.2) was accomplished. Differentiation between the α/β
positions of hydrogen atoms of the methylene groups in the steroid core
was achieved through one-dimensional selective ROESY experiments
(Fig. S9). Irradiation of the δHα-9=3.23 ppm signal resulted ROE re-
sponses on Hα-2, Hα-4 and Hα-12, respectively, and this proved not
only their signal assignment but also the retained cis-type junction of
the A/B rings. Inserting the one-dimensional selROE on H-9 spectrum
(see red line in Fig. S13) into the band-selective HSQC convincingly
demonstrated the unambiguous differentiation of methylene groups in
positions 11 and 17, despite their rather similar chemical shifts. The
HMBC spectrum (Fig. S14) provided the H/C correlations (2,3J(H,C).
Considering the H3-19/C and H3-18/C section of HMBC (shown in Fig.
S14), the cross-peaks of the H3-19 methyl hydrogens unambiguously
assigned signals of the quaternary C-5 and C-10, the tertiary C-9, and
the secondary C-1, and the H3-18 hydrogens assigned the quaternary C-
13 and C-14, tertiary C-17 and secondary C-12 signals.
Compound 12 retained the characteristic UV spectrum of its par-
ental compound calonysterone (6). The structural formula of compound
12 was established as C21H26O5 by means of HRMS ([M+H]+ calcu-
lated: 359.18530, found: 359.18602). HPLC chromatogram and UV
spectrum of compound 12 are available as Supplementary Information:
Fig. S51 together with NMR spectra: Fig. S15–Fig. S18. To facilitate the
evaluation of the HSQC spectrum (Fig. S17) we have inserted the one-
dimensional selTOCSY spectrum with irradiation on Hα-12 (see green
line), from which the separately appearing Hα-11/Hβ-11 signals (2.73/
2.65 ppm) assigned δC-11 at 25.6 ppm. To verify the δC-4=27.6 ppm
assignment, we also utilized selROE on H3-19 (see red line), where the
ROE response at 2.54 ppm unambiguously marked out Hβ-4.
Compound 13 showed a slight hypsochromic shift in its UV spec-
trum as compared to that of poststerone (7), rising the suspicion that it
might be a 9-hydroxylated derivative expectable to form analogously to
our previous results on the autoxidation of 20E (1) [19]. The molecular
formula was established as C21H30O6 by means of HRMS ([M+H]+
calculated: 379.21206, found: 379.21210). The 1H and 13C NMR
spectra revealed this compound to be the analog of the natural product
9α,20-dihydroxyecdysone. The chemical shifts correlated well with the
values of C-1 to C-16 reported earlier for this compound [28]. The δH3-
21 signal at 2.17 ppm, δC-21 and δC-20 peaks, at 31.6 and 212.3 ppm,
respectively, demonstrate the presence of the CH3-C]O group attached
to C-17. HPLC chromatogram and UV spectrum of compound 13 is
available as Supplementary Information (Fig. S52).
The UV spectrum of compound 14 was similar to that of 13, and its
molecular formula was also established as the same, C21H30O6, by
means of HRMS ([M+H]+ calculated: 379.21206 found: 379.21246).
HPLC chromatogram and UV spectrum of compound 14 are available as
Supplementary Information: Fig. S53 together with NMR spectra: Fig.
S19−Fig. S23. In the DEPTQ measurement (Fig. S20) the C-9 signal
remained under the noise level. The H3-19/C-9 HMBC cross-peak
(1.10/76.2 ppm, see Fig. S23) identified the C-9 signal whose high
chemical shift of δC-9= 76.2 ppm proved the OH substituent at this
position. The selROE experiments (Fig. S21) on H3-19 (see green line)
and on H-5 (purple line) revealed the trans type A/B ring-junction and
the Hα-5 configuration, evidencing that is this compound is the Hα-5
epimer of compound 13.
Compound 15 exhibited a characteristic UV spectrum similar to that
previously found for 14,15-dihydro-14α-hydroxycalonysterone, a pro-
duct of the autoxidation of 20E (1) [19]. The molecular formula of
compound 15 was established as C21H28O6 by means of HRMS
([M+H]+ calculated: 377.19641, found: 377.19621). HPLC chroma-
togram and UV spectrum of compound 15 are available as Supple-
mentary Information: Fig. S54 together with NMR spectra: Fig.
S24−Fig. S28. The δH3-21 signal at 2.17 ppm, δC-21 and δC-20 peaks,
at 31.6 and 213.4 ppm, respectively, verified that the CH3-C]O group
attached to C-17 was retained. The appearance of a C]O signal at
180.9 ppm indicated its cross-conjugated arrangement. The HMBC (Fig.
S28) correlations of H3-19 (1.50/42.1 and 1.50/42.6, respectively) as-
signed the quaternary C-10 and H2C-1 methylene moieties, furthermore
the 1.50/133.7 and 1.50/168.2 responses proved the presence of qua-
ternary sp2 C= atoms in positions C-5 and C-9, which together showed
the B ring as a Δ5,6-7-one-Δ8,9 chromophore. The δ1H and δ13C values of
the A/B rings (see Table 1 and 2) of 15 correlate well with the corre-
sponding values of 12, revealing that both compounds contain the same
structural moieties at this region. On the other hand, the HMBC cross-
peak H3-18/C-14 (0.66/82.1) of compound 15 revealed that, instead of
the Δ14,15C=CH ethylene moiety (see structure 12 in Fig. 2), the HO-
14α group of the parental poststerone 7 remained intact. Differentia-
tion between the α/β positions of the diastereotopic methylene hy-
drogens of the skeleton was achieved by selective one-dimensional
ROESY experiments (Fig. S26), irradiating the H3-18 and H3-19 atoms,
respectively.
Compound 16 showed a characteristic UV spectrum similar to that
previously found for isocalonysterone, the desmotropic pair of calo-
nysterone (6), forming through the autoxidation of 20E (1) [19]. The
molecular formula of compound 16 was established as C21H26O5, the
same as that of compound 12 ([M+H]+ calculated: 359.18530, found:
359.18592). HPLC chromatogram and UV spectrum of compound 16
are available as Supplementary Information: Fig. S55 together with
NMR spectra: Figs. S29 and S30. The 1H and 13C (APT) NMR spectra
revealed this compound to be the 17-acetyl analog of isocalonysterone
and the chemical shifts correlated well with the values of C-1 to C-16
reported earlier for isocalonysterone [19], moreover the signals of the
17 CH3-C]O group were measured at δH3-21 2.23 ppm, δC-21 and δC-
20 peaks, at 31.4 and 211.4 ppm, respectively.
In case of compound 17, the UV spectrum did not provide relevant
structural information. The molecular formula of this compound was
established as C21H28O4 by means of HRMS ([M+H]+ calculated:
345.20603, found: 345.20683). The number of double bond equivalents
in compound 17 increased to eight, indicating that this compound
contains one more double bound than its parent compound 7. Twenty
one 13C signals were discernible in the DEPTQ spectrum of 17 (Fig. S32)
indicating the presence of three methyl, six methylene, four sp3 CH
methyne and one sp2 =CH groups, along with two quaternary sp3 and
five quaternary sp2 carbon atoms, the latter including two non-con-
jugated C]O (δ 215.0 and 211.6 ppm) moieties. Integration of the
signals in the 1H NMR spectrum (Fig. S31) obtained in methanol‑d4
summed up to 26H atoms. Considering the nearly identical δC-2 and
δC-3 chemical shifts of compound 17 and the parental 7, both of these
should have HO- substituents, and thus compound 17 contains 28 hy-
drogen atoms, coherently with the HRMS results. The HMBC (Fig. S35)
correlations of H3-19 (1.01/38.1, 1.01/44.3 and 1.01/54.1,
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respectively) assigned the H2C-1 methylene, the quaternary C-10 and
HC-5 moieties, furthermore the 1.01/137.4 responses proved the pre-
sence of quaternary sp2 =C atom in position C-9. The H3-18 HMBC
correlations assigned C-12, C-13 and C-16 atoms at 37.0, 47.5 and
65.0 ppm, respectively. Moreover, the 1.01/147.3 (H3-18/C-14) corre-
lation revealed the presence of a Δ14,15C=CH ethylene moiety in the
D-ring of the steroid skeleton. The H-15/C-8 HMBC cross-peak estab-
lished the Δ8,9 position of the second conjugated double bond. HMBC
correlations of H-5 (2.49 dd, 12.8 and 4.0 Hz) verified the assignment of
δO=C-6 (215.0 ppm) and δH2C-7 (39.8 ppm) signals, respectively.
Differentiation between the α/β hydrogens of the skeleton was
achieved by selective one-dimensional ROESY experiments (Fig. S33),
irradiating the H3-18 and H3-19 atoms. Checking the literary data re-
vealed that compound 17 was formerly reported by Galbrait and his co-
workers [29] in 1969 as a decomposition product of compound 7 after
refluxing it in 0.5 N HCl in ethanol. Limited 1H NMR data in CDCl3 were
given, and only the three methyl signals and the allyl hydrogen were
assigned. Here we provide a complete 1H and 13C NMR signal assign-
ment for this compound in methanol‑d4. HPLC chromatogram and UV
spectra (Fig. S56), and the NMR spectra of compound 17 (Fig. S31–S35)
are available as Supplementary Information.
Compound 18 also did not show analogous UV spectrum to any of
the known autoxidized metabolites of 20E (1) [19]. HPLC chromato-
gram and UV spectrum of compound 18 are available as Supplementary
Information (Fig. S57). According to our NMR protocol, first we per-
formed the 1H, DEPTQ, selROE, HSQC and HMBC measurements in
methanol‑d4 (Supplementary Information: Figs. S36–S40). From these,
we managed to assign the 13C and 1H signals of 18 in this solvent,
certainly without the OH peaks. Taking into account the anomalous δC-
2= 109.0 ppm chemical shift of this quaternary carbon atom, attach-
ment of a second oxygen substituent (e.g. –OH, –OOH, –OC) to C-2 was
suspected. In analogous 9α-OH substituted ecdysteroids (e.g. 13 and
14) the value of chemical shift for C-9 is expected around 76 ppm, but
now in compound 18 it is δC-9= 83.2 ppm, suggesting the presence of
an -OOH or -OC substituent. To overcome this uncertainty, we evapo-
rated the methanol solvent and all NMR investigations were subse-
quently performed in dimethyl sulfoxide-d6 (Supplementary Informa-
tion: Fig. S41–S45). In the DEPTQ spectrum (see Figs. S42), we
identified the signals of three CH3, six CH2, three sp3 CH, one =CH, and
eight quaternary carbon atoms including five sp3 and one sp2 carbons,
and two C]O groups. There are only three 1H signals (6.63 s, 4.49 s and
5.00d (3.9 Hz) without 1J(CH) correlation in the HSQC spectrum,
proving the presence of three hydroxyl groups in compound 18. The H3-
18/C and H3-19/C HMBC correlations over two and three bonds (2,3J
(H,C)) provided the unequivocal assignment of C-12, C-13, C-14, and C-
17 atoms, and C-1, C-5, C-9, and C-10 atoms, respectively (Fig. S45).
The assignment of the detected hydroxyl signals to HO-2, HO-14 and
HO-3 groups is straightforward on the basis of their HMBC cross-peaks.
Whereas the HO- signal at 6.63 s shows 3J(H,C) correlation with C-1
(37.8 ppm), this hydroxyl group is obviously connected to the qua-
ternary C-2 (107.8 ppm). The second oxygen atom attached to this
extremely deshielded C-2 forms a bridge to C-9 resulting a new five-
membered ring in compound 18. The second singlet HO-14 hydroxyl
signal (4.49 s) showed cross-peaks not only with C-14, but also with the
quaternary sp2 C-8 (152.4 ppm), revealing the presence of the 6-one-
Δ7,8 moiety. The H-7/C-5 and H-7/C-9 correlations completed the 13C
assignment. This way the molecular formula should be C21H28O6
(DBE=8), which was then subsequently supported by HRMS ([M
+H]+ calculated: 377.19586, found: 377.19625). One-dimensional
selective ROESY experiments allowed differentiation between the α/β
hydrogen atoms in the steroid core, and also proved the cis-type junc-
tion of the A/B rings (Fig. S43). To achieve an exact 1H assignment even
in case of strongly overlapping signals, the selTOCSY experiment was
the method of choice. Irradiation on H-17 (3.20 ppm) resulted selec-
tively the 1H signals of the D-ring (see the green line inserted into the
edHSQC spectrum of 18 in Fig. S44), whereas the experiment on Hα-12
(2.21 ppm) showed the spin system of the C-ring (inserted red line).
When comparing the oxidized products obtained from the base-
catalyzed autoxidation of 20E (1) [19] with those obtained in this study
from poststerone (7), the formation of both similar and different
structures can be observed. Compound 12 was also one of the reaction
products, even though with a lower yield than from the straightforward
side-chain cleavage of calonysterone (6). Compounds 12–16 are the
cleaved side-chain analogues of previously isolated compounds from
the base-catalyzed autoxidation of 20E (1), while 17 and 18 represent
the results of previously unobserved oxidative transformations.
2.3. Bioactivity on the Akt phosphorylation
The compounds were tested for their capacity to influence the Akt
phosphorylation in murine C2C12 skeletal myotubes. The observed
activities at 10 µM concentration are shown in Fig. 3.
Fig. 3. Activity of compounds 7–18 as compared to the control (C) on the Akt phosphorylation in murine skeletal muscle myotubes. Quantification of Western blots
was performed by ImageJ; error bars represent SEM from four parallel experiments. a: p < 0.05; b: p < 0.01; c: p < 0.001.
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With the exception of the side-chain cleaved derivatives of 2-deoxy-
20-hydroxyecdysone (2), ajugasterone C (3) and polypodine B (4) (i.e.
compounds 8, 9 and 10, respectively), all tested compounds demon-
strated the ability to increase the activation of Akt. In particular, the
side-chain cleaved analogs of dacryhainansterone (5), calonysterone (6)
and isocalonysterone (i.e. compounds 11, 12 and 16, respectively)
showed the strongest activity in this regard. All of these compounds
express higher degree of unsaturation due to further conjugation ex-
tended to their D and/or C rings. This suggests that further double
bonds conjugated with those present in the ecdysteroid B-ring may
positively impact the bioactivities of these compounds in mammalian
cells, and that such compounds might have stronger anabolic, anti-
diabetic and anti-apoptotic activities than the more saturated ones in-
cluding the abundant 20E (1) and its known in vivo metabolites [15].
On the other hand, when a separate experiment was performed to test
poststerone (7) in comparison with 20E (1), it was found a weaker
activator of Akt (293.3 ± 68.3% vs. 537.1 ± 25.3% activation at
10 µM, respectively, n= 6. Interestingly, however, poststerone (7) was
also active at as low as 10 nM concentration (263.4 ± 69.6% activa-
tion, n=6), where 20E (1) was already inactive. For the dose-de-
pendency observed in this experiment, see Supplementary Information,
Fig. S58.
The well-known role of Akt in driving cancer [30] should also be
taken into account when interpreting such bioactivity results. At this
point it is impossible to make a sound judgment whether or not a
stronger in vitro activation of this protein kinase would have in vivo
relevance, and particularly if this would confer ecdysteroid metabolites
any pro-cancerous risk. Current experiences with the apparent safety of
ingesting large (up to several grams) doses of ecdysteroids by sportsmen
at least do not seem to raise concerns, even though long-term safety of
such a practice has never been studied in humans. Nevertheless, our
results clearly show that side-chain cleaved metabolites of ecdysteroids
accompanying 20E (1) within plant extracts have all the potential to
significantly contribute to the complex bioactivity.
3. Conclusions
By using two different chemical strategies (oxidative side-chain
cleavage of various phytoecdysteroids and autoxidation of poststerone),
a set of semi-synthetic side-chain cleaved ecdysteroids was obtained
from acceptable to good yields. In particular, poststerone could be
obtained with an isolated yield of as high as 81.35%. Comprehensive
NMR spectroscopic techniques allowed a complete signal assignment
for each new compound. Several of the new compounds are derivatives
of known phytoecdysteroids with an intact side-chain. Since the side-
chain cleavage is a known metabolic step of 20E in rodents, the pre-
pared compounds can be assumed as potential in vivo metabolites of the
corresponding phytoecdysteroids.
The compounds showed the ability to increase the activation of
protein kinase B in C2C12 myotubes in murine skeletal muscle cells.
Our results suggest that, similarly to our most recent results with
poststerone, the metabolic step of side-chain cleavage leads to com-
pounds with altered, and apparently increased bioactivity in mammals.
Such compounds can reasonably be expected to significantly contribute
to the overall activity observed after the consumption of preparations
(e.g. food supplements) containing a variety of phytoecdysteroids.
Moreover, these metabolites are potentially valuable leads towards
possible ecdysteroid-inspired drug discovery initiatives.
4. Materials and methods
4.1. Starting materials
20-Hydroxyecdysone (1) with a purity of 90%, originated from the
roots of Cyanotis arachnoidea was purchased from Shaanxi KingSci
Biotechnology Co., Ltd. (Shanghai, China). A purification step was
performed by recrystallization from ethyl acetate - methanol (2:1, v/v)
to reach a 97.8% purity by means of RP-HPLC.
2-Deoxy-20-hydroxyecdysone (2) was previously isolated by our
research group from Silene italica ssp. nemoralis [31], ajugasterone C (3),
polypodine B (4) were obtained from our previous isolation from Ser-
ratula wolffii [32]. Compounds 2, 3 and 4 possessed a purity of> 95%
by means of RP-HPLC. Dacryhainansterone (5) and calonysterone (6)
were isolated in our laboratory with a purity of 99.1% and 99.7%, re-
spectively, from a commercial extract of Cyanotis arachnoidea [33].
4.2. General methods
All reagents and solvents were obtained from commercially avail-
able sources and were used without further purification.
Reactions’ progress were monitored by NP-TLC performed on silica
plates (Silica gel 60F254, E. Merck, Germany), by using the solvent
system composed of ethyl acetate - ethanol - water (12:1:0.5, v/v/v).
Visualizations were performed under UV light λ1=254 nm and after
spraying with vanillin/sulfuric acid reagent under λ2=365 nm.
Compounds were fractionated and/or purified by using different
chromatographic techniques. RP-HPLC for semi-preparative purifica-
tions was carried out on an Agilent 1100 series (Waters Co., Milford,
MA, USA) connected to a Jasco UV-2075 detector (Jasco Co., Tokyo,
Japan). RP-HPLC for preparative purifications was performed on a
Waters 600 Pump connected to a Waters 2487 Dual λ Absorbance
Detector (Waters Co., Milford, MA, USA). Rotation planar chromato-
graphy was performed on a Chromatotron device (Harrison Research,
Palo Alto, CA, USA). Flash chromatography was performed on a
CombiFlash® Rf+ apparatus (Teledyne Isco, Lincoln, USA) with an 80 g
HP Silica RediSep® Rf Gold column (Teledyne Isco, Lincoln, USA).
Centrifugal Partition Chromatography was performed on an Armen
Spot CPC 250ml (Armen Instrument, Saint Ave, France) system com-
posed of an Armen Spot Prep II equipment and an Armen Spot CPC
multilayer coil separation column, and controlled by the Armen Glider
CPC software. Optimization of the CPC separation was through fol-
lowing well-established general concepts published in the literature
[33–36].
Purity of the obtained compounds was determined by RP-HPLC
analyses on a system of two Jasco PU-2080 pumps, a Jasco AS-2055Plus
intelligent sampler connected to a JASCO LC-Net II/ADC equipped with
a Jasco MD-2010 Plus PDA detector (Jasco Co., Tokyo, Japan). Turbo
ion spray tandem MS of compounds 8 and 10 were recorded on a API
2000 triple quadrupole tandem mass spectrometer (AB SCIEX, Foster
City, CA, USA) equipped with ESI ion source that was used in the po-
sitive mode. HRMS data for compounds 12–18 were recorded on a
Waters Acquity I-Class UHPLC system (Waters Co., Milford, MA, USA)
coupled with a Thermo Scientific Q Exactive Plus Orbitrap mass spec-
trometer equipped with HESI ion source (Thermo Fisher Scientific,
Scoresby, Australia).
1H (500.1MHz) and 13C (125.6MHz) NMR spectra of compounds
were recorded at room temperature on a Bruker 500 Avance III NMR
spectrometer equipped with cryogenic probe head, or on a Bruker
Avance 500 NMR spectrometer. Amounts of approximately 0.7–5mg of
compounds were dissolved in 0.1 ml of methanol‑d4 and transferred to
2.5 mm Bruker MATCH NMR sample tube (Bruker). Chemical shifts are
given on the δ-scale and are referenced to the solvent (methanol‑d4:
δC= 49.1 and δH= 3.31 ppm). NMR data of compound 18 were also
determined in dimethyl sulfoxide-d6 (δC= 39.5 and δH=2.50 ppm).
Pulse programs of all experiments (one-dimensional 1H, 13C, DEPTQ,
DEPT-135, APT, sel-TOCSY, sel-ROE (τmix: 300ms), two-dimensional
1H,1H-COSY, gs-HSQC, edited gs-HSQC, gs-HMBC and band-selective
HSQC and band-selective HMBC) were taken from the Bruker software
library.
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4.3. Synthesis
4.3.1. Synthesis of compounds 7–12 through oxidative side-chain cleavage
of phytoecdysteroids 1–6
Synthesis of poststerone (7). 20-hydroxyecdysone (1) was used as
starting material for the synthesis of poststerone (7). 5.0 g of 20E (1)
was dissolved in 400ml of methanol, 1 equiv. of PIDA was added, and
the solution was stirred at room temperature for 45min. The reaction
mixture was then neutralized with a 5% aqueous solution of NaHCO3,
and the solvent was evaporated at 40 °C under vacuum. The residue was
dissolved in methanol, and 12 g of silica powder was added. The solvent
was evaporated under vacuum, and the dried extract adsorbed onto
silica (‘dried solid sample loading’ technique) was transferred to a
universal Rf cartridge (Teledyne Isco, Lincoln, USA). For the purifica-
tion, flash chromatography was used with a mobile phase of n-hexane -
dichloromethane (6:4, v/v; solvent A), and dichloromethane - methanol
(1:1, v/v; solvent B), and a 40min gradient program of 0–30% B in A
was applied at a flow rate of 60ml/min. Compound 7 was obtained
with an isolated yield of 81.41% (3.07 g).
General procedure for the synthesis of compounds 8–11.
Compounds 2–5 were used as starting materials for the synthesis of
compounds 8, 9, 10 and 11, respectively. Each starting material (2–5)
was dissolved in methanol to a final concentration of 100mM (2, 5:
46 mg; 3: 48mg; 4: 50mg), and 1.2 equiv. of PIFA was added. The
mixtures were stirred for 60min at room temperature. The reactions
were stopped by neutralizing the pH by using a 5% aqueous solution of
NaHCO3, followed by evaporation to dryness. Each residue was dis-
solved in ethyl acetate and filtered through silica, then dried.
Compounds 8 and 9 were purified over preparative RP-HPLC applying a
Kinetex XB-C18 (5 µm, 250 x 21.2mm) column with 50% aqueous
methanol as eluent at a flow rate of 10ml/min, detecting at 254 nm.
Compounds 8 and 9 were isolated at 56.4% (19.5 mg) and 62.6%
(22.7 mg) yields, respectively. Compounds 10 and 11 were purified
over RPC using a four-step gradient elution with cyclohexane - ethyl
acetate (1:1 and 1:5, v/v) and ethyl acetate - ethanol (12:1 and 6:1, v/
v), with 80ml for each solvent, and 23 fractions were collected.
Compounds 10 and 11 were obtained at 60.2% (21.6 mg) and 59.5%
(22.7 mg) yield, respectively.
Synthesis of compound 12. Calonysterone (6) was used as starting
material for the synthesis of compound 12. 50mg of calonysterone (6)
was dissolved in 12.5ml methanol, 1 equiv. of PIDA was added, and the
solution was stirred at room temperature for 60min. The reaction was
stopped by adjusting the pH of the final mixture to neutral with a 5%
aqueous solution of NaHCO3. After evaporation of the solvent under
nitrogen, the residue was purified by CPC in ascending mode with a
biphasic solvent system composed of n-hexane - ethyl acetate - me-
thanol - water (3:10:3:10, v/v/v/v). The solvent system offered the
following separation characteristics: a very short settling time (17 s),
the volume ratio of the upper and lower phases was 0.86, and the re-
tention volume ratio Sf was 0.68. The equipment optimized parameters
were as follows: constant pressure of 86 bars, flow rate of 10ml/min,
and rotation speed of 2600 rpm. The purification was performed
through a single injection and an altogether 94.42% of the initial
weight was recovered after the separation. Compound 12 was obtained
with a yield of 51.8% (19.5 mg).
4.3.2. Synthesis of compounds 12–18 through base-catalyzed autoxidation
of poststerone (7)
The base-catalyzed autoxidation of poststerone (7) was performed
by dissolving 450mg of poststerone (7) in a mixture of 10ml of MeOH
and 80ml of water, then 500mg of NaOH dissolved in 10ml of water
was added. The reaction mixture was stirred for 4 h at room tempera-
ture, and the reaction was stopped by neutralizing the mixture with a
9.6% aqueous solution of acetic acid. After evaporating the solvent
under nitrogen stream, the residue was pre-purified by solid-phase ex-
traction through silica using methanol as eluent, then dried.
The reaction mixture was subsequently fractionated by CPC in as-
cending mode, by using the biphasic solvent system previously devel-
oped in our laboratory for the separation of 20E (1) and its oxidized
derivatives [19]; it was composed of ethyl acetate - water - methanol
(20:20:1, v/v/v). The equipment optimized parameters were settled as
follows: constant pressure of 80 bar, flow rate of 10ml/min and rota-
tion speed of 2900 rpm. The fractionation was performed through four
consecutive injections, and an altogether 95.43% of the initial weight
was recovered after the separation. The CPC fractions were combined
based on their NP-TLC fingerprints, evaporated under vacuum at 40 °C,
dissolved in methanol and investigated by RP-HPLC on a Kinetex XB C-
18 (5 μm, 250×4.6mm) column with an isocratic solvent system of
23% aqueous acetonitrile at a flow rate of 1ml/min. Fractions 6, 7 and
combined fractions 11–13 were selected for additional purification
steps. Fraction 6 was further purified over semi-preparative RP-HPLC
with 30% aqueous acetonitrile at a flow rate of 3ml/min using a Ge-
mini C18 (5 μm, 250×10mm) column to yield compounds 12 (1.5mg,
0.34%) and 16 (3.76mg, 0.84%). Fraction 7 was further purified over
semi-preparative RP-HPLC with 27% aqueous acetonitrile at a flow rate
of 3ml/min using a Gemini C18 (5 μm, 250×10mm) column to yield
compound 17 (10.61mg, 2.48%). The CPC combined fractions 11–13
were further purified over semi-preparative RP-HPLC with 20% aqu-
eous acetonitrile at a flow rate of 3ml/min using a Luna Phenyl-Hexyl
(5 μm, 250× 10mm) column to yield compounds 13 (10.2mg, 2.17%),
14 (5.7mg, 1.21%), 15 (11.3 mg, 2.42%) and 18 (4.6mg, 1.00%).
In order to obtain more amounts of the above compounds, the re-
action was repeated by using another 500mg of poststerone (7) that
was stirred for 7 h, and the work-up procedure consisted of the same
purification steps as detailed above. The isolated yields in this case were
as follows: compound 13 (27.9mg, 5.34%), compound 14 (3.04mg,
0.58%), compound 15 (20mg, 3.85%), compound 16 (20mg, 4.04%)
and compound 18 (5.72mg, 1.1%).
4.4. Bioactivity testing
Mouse C2C12 skeletal myoblasts (BCRC#60083) were purchased
from the Bioresource Collection and Research Center (BCRC, Food
Industry Research and Development Institute, Taiwan). The cells were
seeded in 6-well plates and maintained in high-glucose Dulbecco’s
modified Eagle’s medium (DMEM) with 10% fetal bovine serum and 1%
penicillin/streptomycin solution in a humidified atmosphere of 95% air
and 5% CO2 at 37 °C. After reaching 100% confluence, C2C12 myo-
blasts were cultured in differentiation medium (DMEM containing
4500mg/L D-glucose and 10% horse serum), and the medium was
changed every 2 days. The cells became skeletal myotubes after 8 days
of differentiation. Then, the culture medium was changed to serum free
normal-glucose DMEM with or without 10 µM of each test compound.
After 2 h, the cells were lysed with 500 µL of 1× sample buffer
(62.5 mM Tris-HCl, pH 6.8; 10% glycerol; 2% SDS; 50mM DTT;
0.0025% bromophenol blue), sonicated for 10–15 s, and heated to
95–100 °C for 5min. For analysis of AKT activation, the cell lysate was
loaded and separated on 10% SDS-polyacrylamide gels. Proteins were
then transferred to PVDF membranes and detected using phosphory-
lated and total Akt antibodies (Cell Signaling Technology, Inc., Danvers,
MA, USA).
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